DLD and melanoma: Therefore, our proteomic, structural, and functional results strongly suggest that DLD, as a key enzyme in several multi-enzymatic complexes involved in mitochondrial energy metabolism, may represent a novel and suitable target for the treatment of BRAFi-resistant melanoma.